Adverse drug reactions due to linezolid in the programmatic management of drug-resistant tuberculosis in India: A retrospective multicenter study

This publication has 19 references indexed in Scilit:

• Linezolid use for drug-resistant tuberculosis in Georgia: a retrospective cohort study
  The International Journal of Tuberculosis and Lung Disease, 2020
• Changes of vitamins B1, B12 as predicting factors of peripheral polyneuropathy in pulmonary tuberculosis patients
  Archives of the Balkan Medical Union, 2020
• Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
  American Journal of Respiratory and Critical Care Medicine, 2019
• Does linezolid have a role in shortening treatment of tuberculosis?
  Clinical Microbiology and Infection, 2019
• Linezolid-based Regimens for Multidrug-resistant Tuberculosis (TB): A Systematic Review to Establish or Revise the Current Recommended Dose for TB Treatment
  Clinical Infectious Diseases, 2018
• The risk factors of linezolid-induced lactic acidosis
  Medicine, 2018
• Evolving strategies for dose optimization of linezolid for treatment of tuberculosis
  The International Journal of Tuberculosis and Lung Disease, 2016
• Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China
  European Respiratory Journal, 2014
• Most of the extant mtDNA boundaries in South and Southwest Asia were likely shaped during the initial settlement of Eurasia by anatomically modern humans
  BMC Genomic Data, 2004
• A method for estimating the probability of adverse drug reactions
  Clinical Pharmacology & Therapeutics, 1981